Understanding why probiotic therapies can be effective in treating IBD.
about
Probiotics in the management of ulcerative colitisProbiotics for prevention of radiation-induced diarrhea: A meta-analysis of randomized controlled trialsLive Combined Bacillus subtilis and Enterococcus faecium Ameliorate Murine Experimental Colitis by ImmunosuppressionPolyunsaturated fatty acids modify expression of TGF-β in a co-culture model ultilising human colorectal cells and human peripheral blood mononuclear cells exposed to Lactobacillus gasseri, Escherichia coli and Staphylococcus aureus.Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.Probiotics and the gut microbiota in intestinal health and diseaseIsolated exopolysaccharides from Lactobacillus rhamnosus GG alleviated adipogenesis mediated by TLR2 in mice.Probiotics for preventive health.Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii.Bugs & us: the role of the gut in autoimmunity.Innate immune dysfunction in acute and chronic liver disease.The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease.[Microbiota and probiotics: effects on human health].Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system.Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse.Toll-like receptor 2 monoclonal antibody or/and Toll-like receptor 4 monoclonal antibody increase counts of Lactobacilli and Bifidobacteria in dextran sulfate sodium-induced colitis in mice.
P2860
Q24630676-F1258FD2-1DC9-4ED3-8324-52186805F2B5Q33757954-D72E0F36-A564-4396-AB9A-47EA4F1F6911Q34222447-C09B58E0-3612-4FE7-A526-EC590BA71B14Q34802933-01770478-A9E7-4BDE-A847-DE61D546653EQ36009729-D4AC1F87-15E9-4C23-9730-A4A9C65F2E62Q36567134-2197F1CC-0A9C-4C20-83C1-2B4AE607BA7EQ37369099-B3B90C79-07AA-408B-9D9B-DBE119D5B153Q37423648-6F0F7DC1-11E5-4569-873C-FA0A3DDFC593Q37586528-BC0BDE30-494E-4F90-B3C5-F9B839B57751Q37592375-D8CEA5EB-10D5-4FCC-8535-0E874618CF33Q37666863-CE1DB0BA-121D-4C50-8AF6-3F94BA7E8EB4Q38661453-C55A2532-45C6-4499-B3FE-F71CFE05F385Q39281119-47253EE1-CE0D-45CE-B768-F8F386B8057FQ45573898-6687CFFA-C548-4672-ADFB-26C37B3DDBB1Q49327061-1BD1698D-7099-4095-9CB8-40AE0C541B9FQ54358058-B96A5E30-FDD6-4042-96BF-4776362196D6
P2860
Understanding why probiotic therapies can be effective in treating IBD.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Understanding why probiotic therapies can be effective in treating IBD.
@ast
Understanding why probiotic therapies can be effective in treating IBD.
@en
Understanding why probiotic therapies can be effective in treating IBD.
@nl
type
label
Understanding why probiotic therapies can be effective in treating IBD.
@ast
Understanding why probiotic therapies can be effective in treating IBD.
@en
Understanding why probiotic therapies can be effective in treating IBD.
@nl
prefLabel
Understanding why probiotic therapies can be effective in treating IBD.
@ast
Understanding why probiotic therapies can be effective in treating IBD.
@en
Understanding why probiotic therapies can be effective in treating IBD.
@nl
P1476
Understanding why probiotic therapies can be effective in treating IBD.
@en
P2093
Richard N Fedorak
P304
P356
10.1097/MCG.0B013E31816D922C
P478
42 Suppl 3 Pt 1
P577
2008-09-01T00:00:00Z